Evidence map›Paper›PMID 41078823›Full record

ArticleACS omega2025

Material Extrusion of the Poly(lactic acid)/HAp Nanocomposite Scaffold for Bone Tissue Applications: A Comprehensive Investigation.

Arunkumar Thirugnanasambandam, Ramasamy Nallamuthu, Sanjay Mavinkere Rangappa, Suchart Siengchin, Vishnu Vijay Kumar

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arunkumar ThirugnanasambandamCentre for Sustainable Material and Surface Metamorphosis, Chennai Institute of Technology, Chennai 600069, India.ORCID https://orcid.org/0000-0003-4425-2878
Ramasamy NallamuthuCentre for Sustainable Material and Surface Metamorphosis, Chennai Institute of Technology, Chennai 600069, India.
Sanjay Mavinkere RangappaNatural Composites Research Group Lab, Department of Materials and Production Engineering, The Sirindhorn International Thai-German School of Engineering (TGGS), King Mongkut's University of Technology North Bangkok (KMUTNB), Bangkok 10800, Thailand.ORCID https://orcid.org/0000-0001-8745-9532
Suchart SiengchinNatural Composites Research Group Lab, Department of Materials and Production Engineering, The Sirindhorn International Thai-German School of Engineering (TGGS), King Mongkut's University of Technology North Bangkok (KMUTNB), Bangkok 10800, Thailand.
Vishnu Vijay KumarStructural Engineering, Division of Engineering, New York University Abu Dhabi (NYUAD), Abu Dhabi 129188, United Arab Emirate.ORCID https://orcid.org/0000-0002-3657-6277

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The material extrusion of biodegradable composite scaffolds has emerged as an alternative for addressing the existing challenges associated with bone regeneration. The present study aims to fabricate a 3D-printed bioscaffold to facilitate bone regeneration by interacting with the local extracellular matrix and providing load-bearing capability. Hence, a biodegradable PLA blended with hydroxyapatite (HAp) bioceramic material has been utilized for providing essential properties for bone regeneration applications. The various PLA/HAp blend filaments were fabricated at multiple blending ratios (94/6, 88/12, and 82/18) to examine the most appropriate blend ratio for providing the intended applications. EDAX analysis has been utilized to evaluate the elemental composition of PLA nanocomposites. The intermolecular interaction and degradation temperature (

Identifiers

PMID41078823
PMCPMC12508978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.